Childhood Arthritis: When Joint Pain Affects Kids
https://www.niams.nih.gov/childhood-arthritis-when-joint-pain-affects-kids
Displaying 781 - 800 of 1011 results
A Ray of Hope for a Rare and Deadly Skin Cancer
https://www.niams.nih.gov/ray-hope-rare-and-deadly-skin-cancer
Postbac Poster Day Showcases Young Scientific Talent
https://www.niams.nih.gov/postbac-poster-day-showcases-young-scientific-talent
Promoting a Basic Understanding of Chemical Threats to Skin
Developing medical countermeasures to protect civilians against intentional and accidental toxic chemical exposure that can lead to mass casualties is a major goal of the biodefense program at NIH. More specifically, this goal is executed by the Chemical Countermeasures Research Program (CCRP) administered by NIAID and executed in partnership with several other ICs across the NIH, including NIAMS.
FY 2022 Congressional Justification
https://www.niams.nih.gov/about/budget/fy2022/congressional-justification
Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
Clinical Trials in the Spotlight Main Page The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports a range of clinical trials studying new and existing interventions for prevention and treatment of arthritis, musculoskeletal, and skin diseases. Investigators supported by the NIAMS need your help finding individuals to
Living With Scoliosis
https://www.niams.nih.gov/living-scoliosis
An NIH Health Capsule article. Scoliosis is a disease that causes the spine to curve. It can result in an abnormal s-shaped or c-shaped curve. Anyone can get scoliosis. But it’s most common in children age 11 and older.
Drs. Heidi Kong and Ian Myles — Derm Germs: The Human Skin Microbiome
https://www.niams.nih.gov/drs-heidi-kong-and-ian-myles-derm-germs-human-skin-microbiome
Dr. Heidi Kong uses genomics to uncover the microbe-host interactions taking place all over our skin.
Frequently Asked Questions for PAR-24-289 (R01) and PAR-25-230 (R21): Ancillary Studies to Ongoing Clinical Projects (Clinical Trial Not Allowed)
Applicants with additional questions are highly encouraged to contact their Program Director . These FAQs apply to the following funding opportunities: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (PAR-24-289) Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (PAR-25-230)
Researchers Uncover Clues to Why Some Wounds Don’t Heal
Researchers identify defects in the wound healing process that might explain why diabetic foot ulcers heal slower or not at all.
NIH Researchers Discover a New Inflammatory Disease Called VEXAS
NIH scientists led an international team of researchers toward discovery of a new, adult-onset inflammatory disease abbreviated the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.
The Stephen I. Katz Early Stage Investigator Research Grant Program
Dr. Stephen I. Katz directed the National Institute of Arthritis and Musculoskeletal and Skin Diseases from August 1995 until his death in December 2018. He is remembered as an outstanding scientist, administrator, and civil servant who was committed to excellence, transparency, integrity, and public trust. But perhaps most noteworthy were
Elif Eren, Ph.D.
https://www.niams.nih.gov/about/directory/elif-eren-phd
Dr. Eren is a structural biochemist studying viral protein interactions with host proteins, nucleic acids, and antibodies using x-ray crystallography and cryo-EM. Her research focuses on novel drug targets and therapeutics for HIV-1, HBV, and SARS-CoV-2.
New NIH Research Grants Honor Legacy of Former NIAMS Director Stephen I. Katz, M.D., Ph.D.
We at NIAMS are excited as we look forward to the arrival of Lindsey Criswell as the new Director but our thoughts also turn back to memories of our previous Director, Steve Katz. He was a unique voice who guided the NIAMS as director for more than two decades and who spent his career mentoring the next generations of researchers. With this in mind, I am pleased to share news of new awards that give the NIH a unique way to encourage the scientists of tomorrow.
Frequently Asked Questions for Investigators Conducting NIAMS-Funded Clinical Research Studies
TABLE OF CONTENTS TERMINOLOGIES AND DEFINITIONS GENERAL DATA AND SAFETY MONITORING AND OVERSIGHT STUDY DOCUMENTS NIAMS CLINICAL FUNDING OPPORTUNITIES, REVIEW AND AWARD ANCILLARY STUDIES HUMAN SUBJECTS AND CLINICAL TRIALS INFORMATION FORM CLINICALTRIALS.GOV TRAINING REQUIREMENTS FOR CLINICAL TRIALS
Natalia Acevedo Luna, Ph.D.
https://www.niams.nih.gov/about/directory/natalia-acevedo-luna-phd
Dr. Acevedo Luna is a postdoctoral fellow focusing on the mechanisms of non-coding RNAs acting in trans to regulate the expression of target genes and the modulation of chromatin 3D conformation during skeletal muscle specification and development.